All Stories

  1. Self-Assembling Peptide Gels for 3D Prostate Cancer Spheroid Culture

    Article • Macromolecular Bioscience, October 2018, Wiley

    Dr. Donald Vander Griend

  2. Exosomes secreted by placental stem cells selectively inhibit growth of aggressive prostate cancer cells

    Article • Biochemical and Biophysical Research Communications, May 2018, Elsevier

    Ravi Singh, Dr. Donald Vander Griend

  3. MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease

    Article • Clinical Cancer Research, May 2018, American Association for Cancer Research (AACR)

    Dr. Donald Vander Griend

  4. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017

    Article • Journal of Clinical Oncology, February 2018, American Society of Clinical Oncology (ASCO)

    Dr. Donald Vander Griend

  5. Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction

    Article • American Journal Of Pathology, November 2017, Elsevier

    Dr. Donald Vander Griend

  6. HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions

    Article • Genes & Diseases, June 2017, Elsevier

    Dr. Donald Vander Griend

  7. Contribution of Caudal Müllerian Duct Mesenchyme to Prostate Development

    Article • Stem Cells and Development, November 2016, Mary Ann Liebert Inc

    Dr. Donald Vander Griend

  8. Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer

    Article • Oncotarget, March 2016, Impact Journals, LLC

    Dr. Donald Vander Griend

  9. Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer

    Article • Journal of Translational Medicine, November 2014, Springer Science + Business Media

    Dr. Donald Vander Griend

  10. The pluripotency factor Nanog is directly upregulated by the Androgen Receptor in prostate cancer cells

    Article • The Prostate, August 2014, Wiley

    Dr. Donald Vander Griend

  11. Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer

    Article • Hormones and Cancer, March 2014, Springer Science + Business Media

    Dr. Donald Vander Griend

  12. Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Regulation

    Article • International Journal of Biological Sciences, January 2014, Ivyspring International Publisher

    Dr. Donald Vander Griend

  13. Formation of Human Prostate Epithelium Using Tissue Recombination of Rodent Urogenital Sinus Mesenchyme and Human Stem Cells

    Article • Journal of Visualized Experiments, June 2013, MyJove Corporation

    Dr. Donald Vander Griend

  14. Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer

    Article • PLoS ONE, January 2013, PLOS

    Dr. Donald Vander Griend

  15. Growth kinetics of CD133-positive prostate cancer cells

    Article • The Prostate, November 2012, Wiley

    Dr. Donald Vander Griend

  16. Deregulation of a Hox Protein Regulatory Network Spanning Prostate Cancer Initiation and Progression

    Article • Clinical Cancer Research, June 2012, American Association for Cancer Research (AACR)

    Dr. Donald Vander Griend

  17. Building on the foundation of daring hypotheses: Using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonization

    Article • FEBS Letters, September 2011, Wiley

    Dr. Donald Vander Griend

  18. Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells

    Article • The Prostate, January 2010, Wiley

    Dr. Donald Vander Griend

  19. Dual-label centromere and telomere FISH identifies human, rat, and mouse cell contribution to Multispecies recombinant urogenital sinus xenografts

    Article • The Prostate, October 2009, Wiley

    Dr. Donald Vander Griend

  20. DNA licensing as a novel androgen receptor mediated therapeutic target for prostate cancer

    Article • Endocrine Related Cancer, June 2009, Bioscientifica

    Dr. Donald Vander Griend

  21. Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells

    Article • Molecular Cancer Therapeutics, May 2009, American Association for Cancer Research (AACR)

    Professor Søren Brøgger Christensen, Dr. Donald Vander Griend

  22. The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells

    Article • Cancer Research, December 2008, American Association for Cancer Research (AACR)

    Dr. Donald Vander Griend

  23. Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells

    Article • Proceedings of the National Academy of Sciences, October 2006, Proceedings of the National Academy of Sciences

    Dr. Donald Vander Griend

  24. Low-Calcium Serum-Free Defined Medium Selects for Growth of Normal Prostatic Epithelial Stem Cells

    Article • Cancer Research, September 2006, American Association for Cancer Research (AACR)

    Dr. Donald Vander Griend

  25. The p38 Kinases MKK4 and MKK6 Suppress Metastatic Colonization in Human Ovarian Carcinoma

    Article • Cancer Research, February 2006, American Association for Cancer Research (AACR)

    Dr. Donald Vander Griend

  26. Suppression of Metastatic Colonization by the Context-Dependent Activation of the c-Jun NH2-Terminal Kinase Kinases JNKK1/MKK4 and MKK7

    Article • Cancer Research, December 2005, American Association for Cancer Research (AACR)

    Dr. Donald Vander Griend

  27. Metastasis suppressor genes: signal transduction, cross-talk and the potential for modulating the behavior of metastatic cells

    Article • Anti-Cancer Drugs, July 2004, Wolters Kluwer Health

    Dr. Donald Vander Griend

  28. Article • Clinical & Experimental Metastasis, January 2003, Springer Science + Business Media

    Dr. Donald Vander Griend